Cargando…
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
Background: We aimed to investigate the potential beneficial effect of immunomodulation therapy on the thromboembolic risk in hospitalized COVID-19 patients. Methods: We searched PubMed and Scopus for randomized trials reporting the outcomes of venous thromboembolism (VTE), ischemic stroke or system...
Autores principales: | Sagris, Dimitrios, Florentin, Matilda, Tasoudis, Panagiotis, Korompoki, Eleni, Gatselis, Nikolaos, Giamarellos-Bourboulis, Evangelos J., Milionis, Haralampos, Douketis, James, Spyropoulos, Alex C., Dalekos, George, Ntaios, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617689/ https://www.ncbi.nlm.nih.gov/pubmed/34830648 http://dx.doi.org/10.3390/jcm10225366 |
Ejemplares similares
-
Atrial High‐Rate Episode Duration Thresholds and Thromboembolic Risk: A Systematic Review and Meta‐Analysis
por: Sagris, Dimitrios, et al.
Publicado: (2021) -
Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials
por: Tasoudis, Panagiotis T., et al.
Publicado: (2022) -
Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
por: Dalekos, George N., et al.
Publicado: (2021) -
An overview of diagnosis and management of drug‐induced hypomagnesemia
por: Liamis, George, et al.
Publicado: (2021) -
Monkeypox: A real new warning or just a sign of times?
por: Georgiadou, Sara P., et al.
Publicado: (2023)